Fig. 4From: Influence of insulin resistance on the development of hepatocellular carcinoma after antiviral treatment for non-cirrhotic patients with chronic hepatitis CCumulative incidence of HCC according to insulin resistance (cut-off HOMA-IR 3.0) for non-SVR patients with a low to moderate AFP level (<10 ng/mL) and b high AFP level (≥10 U/L). HCC, hepatocellular carcinoma; HOMA, homeostasis model assessment of insulin resistance; SVR, sustained virological response; AFP, alpha-fetoproteinBack to article page